Page last updated: 2024-10-16

quinacrine and Invasiveness, Neoplasm

quinacrine has been researched along with Invasiveness, Neoplasm in 1 studies

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Research Excerpts

ExcerptRelevanceReference
"Recurrence of invasive breast cancer could arise from the residual cancer cells after comprehensive treatment."5.42Targeting Epirubicin Plus Quinacrine Liposomes Modified with DSPE-PEG2000-C(RGDfK) Conjugate for Eliminating Invasive Breast Cancer. ( Ju, RJ; Li, XT; Li, XY; Lu, WL; Mu, LM; Shi, JF; Sun, MG; Yan, Y; Zeng, F; Zhao, Y, 2015)
"Recurrence of invasive breast cancer could arise from the residual cancer cells after comprehensive treatment."1.42Targeting Epirubicin Plus Quinacrine Liposomes Modified with DSPE-PEG2000-C(RGDfK) Conjugate for Eliminating Invasive Breast Cancer. ( Ju, RJ; Li, XT; Li, XY; Lu, WL; Mu, LM; Shi, JF; Sun, MG; Yan, Y; Zeng, F; Zhao, Y, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sun, MG1
Shi, JF1
Li, XY1
Zhao, Y1
Ju, RJ1
Mu, LM1
Yan, Y1
Li, XT1
Zeng, F1
Lu, WL1

Other Studies

1 other study available for quinacrine and Invasiveness, Neoplasm

ArticleYear
Targeting Epirubicin Plus Quinacrine Liposomes Modified with DSPE-PEG2000-C(RGDfK) Conjugate for Eliminating Invasive Breast Cancer.
    Journal of biomedical nanotechnology, 2015, Volume: 11, Issue:8

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Epirubi

2015